Status:
COMPLETED
Effects of Vitamin D and Omega-3 on Cerebrovascular Disease
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Stroke
Vitamin D
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a completed randomized clinical trial in 25,875 U.S. men and women which investigated whether taking daily dietary supplements of vitamin D3 (2...
Detailed Description
Stroke is a leading cause of disability and death worldwide and is expected to become an even more prevalent cause of disability in the future as the population ages. Understanding risk factors which ...
Eligibility Criteria
Inclusion
- Participants eligible and willing to participate in the main VITAL trial (NCT 01169259) who experience a stroke during follow-up.
Exclusion
- Participants eligible and willing to participate in the main VITAL trial (NCT 01169259) who do not experience a stroke during follow-up.
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 17 2018
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT04070833
Start Date
August 1 2016
End Date
September 17 2018
Last Update
August 15 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.